Home › Biogen Idec and Sobi Present New Data from the Phase 3 Study of Their ...
 

Keywords :   


Biogen Idec and Sobi Present New Data from the Phase 3 Study of Their ...

2013-07-04 18:03:24| Biotech - Topix.net

Biogen Idec and Swedish Orphan Biovitrum AB presented new data that support the clinical and safety profile of their long-lasting recombinant factor VIII candidate ELOCTATE* for hemophilia A. Five platform and oral presentations at the XXIV International Society on Thrombosis and Haemostasis Congress in Amsterdam, The Netherlands, highlight the ... (more)

Tags: of their data present

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.06Atlantic Tropical Weather Outlook
29.06Eastern North Pacific Tropical Weather Outlook
28.06What we learned from IT expert at Post Office inquiry
28.06M&S to launch clothing repairs service
28.06Tropical Depression Two Graphics
28.06Tropical Depression Two Public Advisory Number 1
28.06Summary for Tropical Depression Two (AT2/AL022024)
28.06Tropical Depression Two Forecast Advisory Number 1
More »